Atlas Trials

Recurrent Mucosal Melanoma

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Mucosal Melanoma

RecordFirmDate
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer (NCT05098210)Fred Hutchinson Cancer Center2022-06-09
Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery (NCT02506153)National Cancer Institute (NCI)2015-11-10

Track Recurrent Mucosal Melanoma automatically

Every clearance here is in the API, with alerts when new ones post.